QIAGEN offers sample to insight solutions worldwide. They provide consumables for primary and secondary samples, including nucleic stabilization and purification kits. The company also offers instruments for nucleic acid purification and accessories. QIAGEN provides assays for various applications, such as TB testing, prenatal testing, and viral load monitoring. Their PCR consumables include quantitative PCR, reverse transcription, and combination kits. The company also offers NGS gene panels, library prep kits, and whole genome amplification solutions. They serve customers in molecular diagnostics, academia, pharmaceuticals, and applied testing.
| Indicator | Value |
|---|---|
| PER | 122.8 |
| EV/EBITDA | 23.4 |
| Price/Free Cash Flow' | 20.4 |
| ROIC | 13.6% |
| Net Debt/EBITDA | 1.5 |